Saturday, June 25, 2005

New blood-pressure guidelines pay off — for drug companies

At the American Society of Hypertension (ASH) convention in San Francisco last month, doctors check the Bristol-Myers Squibb counter in a room full of drug-company literature and salespeople. Critics say drug companies, which pay one-third of ASH's $4.4 million budget, exert undue influence on the group.